| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |